Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19

Mingxing Huang; Man Li; Fei Xiao; Jiabi Liang; Pengfei Pang; Tiantian Tang; Shaoxuan Liu; Binghui Chen; Jingxian Shu; Yingying You; Yang Li; Meiwen Tang; Jianhui Zhou; Guanmin Jiang; Jingfen Xiang; Wenxin Hong; Songmei He; Zhaoqin Wang; Jianhua Feng; Changqing Lin; Yinong Ye; Zhilong Wu; Yaocai Li; Bei Zhong; Ruilin Sun; Zhongsi Hong; Jing Liu; Huili Chen; Xiaohua Wang; Zhonghe Li; Duanqing Pei; Lin Tian; Jinyu Xia; Shanping Jiang; Nanshan Zhong; Hong Shan.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20081059

Documentos relacionados

  1. Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19.
  2. Effect of ArtemiC in patients with COVID-19: A Phase II prospective study.
  3. Ivermectin for preventing and treating COVID-19.
  4. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
  5. Inhaled corticosteroids for the treatment of COVID-19.
  6. Duration of infectious viral shedding in patients with mild to moderate COVID-19 treated with REGN-CoV2.
  7. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.
  8. The Life of SARS-CoV-2 Inside Cells: Replication-Transcription Complex Assembly and Function.
  9. Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19.
  10. Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta-analysis.